RICCIARDI NATALE S 4
4 · Asterias Biotherapeutics, Inc. · Filed Jun 25, 2018
Insider Transaction Report
Form 4
RICCIARDI NATALE S
Director
Transactions
- Award
Stock Options
2018-06-21+20,000→ 20,000 totalExercise: $1.75Exp: 2028-06-21→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Option
Exercise: $6.22From: 2015-07-09Exp: 2020-03-31→ Common Stock (20,000 underlying) - 20,000
Stock Option
Exercise: $2.34From: 2014-08-19Exp: 2019-03-31→ Common Stock (20,000 underlying) - 20,000
Stock Option
Exercise: $3.45From: 2017-03-31Exp: 2027-03-29→ Common Stock (20,000 underlying) - 19,706
Series A Common Stock
- 7,353
Warrants
Exercise: $4.37From: 2016-05-13Exp: 2021-05-13→ Common Stock (7,353 underlying) - 20,000
Stock Options
Exercise: $3.64From: 2016-03-31Exp: 2026-02-28→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest equally over the next four quarters, beginning on the June 30, 2018 contingent upon continued service on the Board of Directors.